Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
car-t
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
20 mars 2025 07h00 HE
|
Wugen
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership
19 mars 2025 06h00 HE
|
Allogenica
Allogenica Secures €2.5 Million Grant to Advance Universal CAR-T Therapy and Strengthen France’s Biotherapy Leadership Allogenica received a €2.5 million grant from the French government's France...
CARGO Therapeutics Provides Corporate Update
18 mars 2025 16h05 HE
|
Cargo Therapeutics, Inc.
CARGO Therapeutics Provides Corporate Update
Arcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness Month
18 mars 2025 08h44 HE
|
Today's Marketplace
Today's Marketplace interviews Arcellx CMO and Creighton University to discuss multiple myeloma awareness month.
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
26 févr. 2025 07h00 HE
|
Wugen
Wugen Announces Appointment of Jim Faulkner, Ph.D., as Chief Technology Officer
CERo Therapeutics Holdings, Inc. Highlights Progress
06 févr. 2025 08h15 HE
|
CERo Therapeutics Holdings, Inc.
Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025 SOUTH SAN FRANSCISCO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics...
CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders
06 févr. 2025 07h20 HE
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”) today released a letter to shareholders from the Chairman of the Company’s Board...
Monthly information on share capital and company voting rights
04 févr. 2025 16h30 HE
|
Cellectis Inc.
PARIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of voting...
Vor Bio Announces $55.6 Million Private Placement
27 déc. 2024 09h00 HE
|
Vor Biopharma
Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33ALLO in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with...
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
20 nov. 2024 07h00 HE
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Further to an announcement on October 7, 2024, CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical...